Diagnostic and clinical utility of comprehensive multigene panel testing for patients with neuropathy.

Our results highlight the need for expanded genetic testing guidelines that account for the increased number of genes associated with hereditary neuropathy, address the overlap of acquired and hereditary neuropathy, and provide broader access to genetic diagnosis for patients.